Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01904175|
Recruitment Status : Completed
First Posted : July 22, 2013
Last Update Posted : May 5, 2016
Allogeneic transplantation is used to treat many malignant and non-malignant diseases. The investigators and others have shown that less toxic preparative regimens (reduced intensity or 'mini' transplants) allow reliable allogeneic engraftment and durable remissions, significantly broadening the population of patients who may be offered this therapy to those who are older and more infirmed. The field is now focusing on the period post transplant for approaches to immune recovery leading to improved outcomes.
The primary objective of this registry is to catalogue data from patients who undergo standard of care reduced intensity allogeneic transplantation.
|Condition or disease|
|Hodgkin's Disease Non Hodgkin's Lymphoma Myeloma Leukemia Myelodysplasia|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||48 participants|
|Target Follow-Up Duration:||1 Year|
|Official Title:||Registry Study of T Cell Depleted Allogeneic Non-Myeloablative Stem Cell Transplant Recipients|
|Study Start Date :||August 2013|
|Actual Primary Completion Date :||April 2016|
|Actual Study Completion Date :||April 2016|
Reduced Intensity Allogeneic Transplant
Subjects undergoing a reduced intensity allogeneic stem cell transplant
- Catalogue Data [ Time Frame: 1 year ]Catalogue data from subjects who undergo standard of care reduced intensity allogeneic transplantation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01904175
|United States, North Carolina|
|Duke University Health System|
|Durham, North Carolina, United States, 27710|
|Principal Investigator:||David Rizzieri, MD||Duke Health|